Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey L Greene

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Nature Biotechnology|October 27, 2022
Targeting MYC with modular synthetic transcriptional repressors derived from bHLH DNA-binding domainsThomas E Speltz, Zeyu Qiao, Colin S Swenson, et al.
Molecular Cancer Research : MCR|July 8, 2017
Interferon-Stimulated Genes Are Transcriptionally Repressed by PR in Breast CancerKatherine R Walter, Merit L Goodman, Hari Singhal, et al.
Endocrinology|March 15, 2008
An estrogen receptor-alpha knock-in mutation provides evidence of ligand-independent signaling and allows modulation of ligand-induced pathways in vivoKerstin W Sinkevicius, Joanna E Burdette, Karolina Woloszyn, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
Ceramide-induced Endoplasmic Reticulum Stress as a Targetable Vulnerability in Endocrine Therapy-Resistant Breast CancerPurab Pal, Shweta Chitkara, Godwin K Sarpey, et al.
Molecular Pharmacology|May 10, 2018
Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast CancerPhilipp Y Maximov, Balkees Abderrahman, Sean W Fanning, et al.
EMBO Reports|May 1, 2007
Structural plasticity in the oestrogen receptor ligand-binding domainKendall W Nettles, John B Bruning, German Gil, et al.
BMC Cancer|February 3, 2009
Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic CohortChristopher A Haiman, Rachel R Garcia, Chris Hsu, et al.
Breast Cancer Research and Treatment|December 11, 2012
MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasionJessica Bockhorn, Kathy Yee, Ya-Fang Chang, et al.
Science Advances|July 8, 2016
Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancerHari Singhal, Marianne E Greene, Gerard Tarulli, et al.
Molecular Cancer Research : MCR|June 3, 2026
Ceramide-induced endoplasmic reticulum stress reveals a targetable vulnerability in endocrine therapy-resistant breast cancerPurab Pal, Shweta Chitkara, Godwin K Sarpey, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Nature Biotechnology|October 27, 2022
Targeting MYC with modular synthetic transcriptional repressors derived from bHLH DNA-binding domainsThomas E Speltz, Zeyu Qiao, Colin S Swenson, et al.
Molecular Cancer Research : MCR|July 8, 2017
Interferon-Stimulated Genes Are Transcriptionally Repressed by PR in Breast CancerKatherine R Walter, Merit L Goodman, Hari Singhal, et al.
Endocrinology|March 15, 2008
An estrogen receptor-alpha knock-in mutation provides evidence of ligand-independent signaling and allows modulation of ligand-induced pathways in vivoKerstin W Sinkevicius, Joanna E Burdette, Karolina Woloszyn, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
Ceramide-induced Endoplasmic Reticulum Stress as a Targetable Vulnerability in Endocrine Therapy-Resistant Breast CancerPurab Pal, Shweta Chitkara, Godwin K Sarpey, et al.
Molecular Pharmacology|May 10, 2018
Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast CancerPhilipp Y Maximov, Balkees Abderrahman, Sean W Fanning, et al.
EMBO Reports|May 1, 2007
Structural plasticity in the oestrogen receptor ligand-binding domainKendall W Nettles, John B Bruning, German Gil, et al.
BMC Cancer|February 3, 2009
Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic CohortChristopher A Haiman, Rachel R Garcia, Chris Hsu, et al.
Breast Cancer Research and Treatment|December 11, 2012
MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasionJessica Bockhorn, Kathy Yee, Ya-Fang Chang, et al.
Science Advances|July 8, 2016
Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancerHari Singhal, Marianne E Greene, Gerard Tarulli, et al.
Molecular Cancer Research : MCR|June 3, 2026
Ceramide-induced endoplasmic reticulum stress reveals a targetable vulnerability in endocrine therapy-resistant breast cancerPurab Pal, Shweta Chitkara, Godwin K Sarpey, et al.
Pageof 8